Skip to main content
Top
Published in: Journal of Endocrinological Investigation 12/2014

01-12-2014 | Original Article

Factors related to mortality in patients with papillary and follicular thyroid cancer in long-term follow-up

Authors: Thaís Gomes de Melo, Denise Engelbrecht Zantut-Wittmann, Elizabeth Ficher, Lígia Vera Montalli da Assumpção

Published in: Journal of Endocrinological Investigation | Issue 12/2014

Login to get access

Abstract

Purpose

Differentiated thyroid cancer (DTC) includes papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC). They have different biological behavior but are frequently analyzed together in studies. We aimed to identify factors associated with mortality in those two different cancer subtypes.

Methods

Case series study, with clinical–pathological analysis of the characteristics of 424 patients with PTC and 89 patients with FTC, correlating them to survival rates in a single institution.

Results

Patients were followed from 1983 to 2011. Mean follow-up time was 9.4 years for FTC (range 1–36.6 years) and 6.8 years for PTC (range 1.1–30.7 years). Mean age at diagnosis was 51.2 ± 15.5 for FTC and 41 ± 14.7 years for PTC. 50.62 % of FTC nodules sized 1.1–4 cm and 20 % of PTC sized ≤1 cm. Cox multiple regression analysis evidenced distant metastasis at diagnosis (p = 0.0038; relative risk (RR) 41.247, 95 % confidence interval (CI) 3.317–512.986), lymph node metastasis at diagnosis (p = 0.0081; RR 50.98, 95 % CI 2.783–934.026) and vascular/lymphatic invasion (p = 0.0039; RR 40.424, 95 % CI 3.287–497.177) as factors related to mortality in FTC patients. For PTC, the factors were distant metastasis at diagnosis (p < 0.0001; RR 32.5, 95 % CI 6.676–158.543) and degree of differentiation (poor versus well differentiated, p = 0.003; RR 10.4, 95 % CI 2.218–49.487).

Conclusion

The common factor that influenced mortality for FTC and PTC patients was distant metastasis at diagnosis, increasing mortality rate by 41 times in FTC and 30 times in PTC patients. The different factors influencing mortality for different DTC types highlight the importance of analyzing them separately.
Literature
1.
go back to reference Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225–249PubMedCrossRef Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225–249PubMedCrossRef
2.
go back to reference Chen AY, Jemal A, Ward EM (2009) Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer 115(16):3801–3807PubMedCrossRef Chen AY, Jemal A, Ward EM (2009) Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer 115(16):3801–3807PubMedCrossRef
3.
go back to reference Welker MJ, Orlov D (2003) Thyroid nodules. Am Fam Physician 67(3):559–566PubMed Welker MJ, Orlov D (2003) Thyroid nodules. Am Fam Physician 67(3):559–566PubMed
4.
go back to reference Lang BH, Wong KP, Cheung CY, Wan KY, Lo CY (2013) Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis. Ann Surg Oncol 20(4):1329–1335PubMedCentralPubMedCrossRef Lang BH, Wong KP, Cheung CY, Wan KY, Lo CY (2013) Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis. Ann Surg Oncol 20(4):1329–1335PubMedCentralPubMedCrossRef
5.
go back to reference Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428PubMedCrossRef Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428PubMedCrossRef
6.
go back to reference Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, Ordonez NG (1992) Well-differentiated thyroid carcinoma and the results of various modalities of treatment: a retrospective review of 1599 patients. J Clin Endocrinol Metab 75:714–720PubMed Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, Ordonez NG (1992) Well-differentiated thyroid carcinoma and the results of various modalities of treatment: a retrospective review of 1599 patients. J Clin Endocrinol Metab 75:714–720PubMed
7.
go back to reference Brierley J, Tsang R, Panzarella T, Bana N (2005) Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Clin Endocrinol (Oxf) 63:418–427CrossRef Brierley J, Tsang R, Panzarella T, Bana N (2005) Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Clin Endocrinol (Oxf) 63:418–427CrossRef
8.
go back to reference Lerch H, Schober O, Kuwert T, Saur HB (1997) Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 15:2067–2075PubMed Lerch H, Schober O, Kuwert T, Saur HB (1997) Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 15:2067–2075PubMed
9.
go back to reference Loh KC, Greenspan FS, Gee I, Miller TR, Yeo PP (1997) Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab 82:3553–3562PubMedCrossRef Loh KC, Greenspan FS, Gee I, Miller TR, Yeo PP (1997) Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab 82:3553–3562PubMedCrossRef
10.
11.
go back to reference Lang BH, Lo CY, Chan WF, Lam KY, Wan KY (2007) Prognostic factors in papillary and follicular thyroid carcinoma: implications for cancer staging. Ann Surg Oncol 14:730–738PubMedCrossRef Lang BH, Lo CY, Chan WF, Lam KY, Wan KY (2007) Prognostic factors in papillary and follicular thyroid carcinoma: implications for cancer staging. Ann Surg Oncol 14:730–738PubMedCrossRef
12.
go back to reference Lee J, Soh EY (2010) Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis: clinical outcomes and prognostic factors. Ann Surg 251:114–119PubMedCrossRef Lee J, Soh EY (2010) Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis: clinical outcomes and prognostic factors. Ann Surg 251:114–119PubMedCrossRef
13.
go back to reference Klein Hesselink EN, Klein Hesselink MS, de Bock GH, Gansevoort RT, Bakker SJ, Vredeveld EJ, van der Horst-Schrivers AN, van der Horst IC, Kamphuisen PW, Plukker JT, Links TP, Lefrandt JD (2013) Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study. J Clin Oncol 31(32):4046–4053PubMedCrossRef Klein Hesselink EN, Klein Hesselink MS, de Bock GH, Gansevoort RT, Bakker SJ, Vredeveld EJ, van der Horst-Schrivers AN, van der Horst IC, Kamphuisen PW, Plukker JT, Links TP, Lefrandt JD (2013) Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study. J Clin Oncol 31(32):4046–4053PubMedCrossRef
14.
go back to reference Blesa JMG, Pulido EG, Pulla MP, Candel VA, Canales JBL, Arrom MG, Rico PM (2010) Old and new insights in the treatment of thyroid carcinoma. J Thyroid Res. doi:10.4061/2010/279468 Blesa JMG, Pulido EG, Pulla MP, Candel VA, Canales JBL, Arrom MG, Rico PM (2010) Old and new insights in the treatment of thyroid carcinoma. J Thyroid Res. doi:10.​4061/​2010/​279468
15.
go back to reference Czarniecka A, Jarzab M, Krajewska J, Chmielik E, Szcześniak-Klusek B, Stobiecka E, Kokot R, Sacher A, Poltorak S, Wloch J (2010) Prognostic value of lymph node metastases of differentiated thyroid cancer (DTC) according to the local advancement and range of surgical excision. Thyroid Res. doi:10.1186/1756-6614-3-8 PubMedCentralPubMed Czarniecka A, Jarzab M, Krajewska J, Chmielik E, Szcześniak-Klusek B, Stobiecka E, Kokot R, Sacher A, Poltorak S, Wloch J (2010) Prognostic value of lymph node metastases of differentiated thyroid cancer (DTC) according to the local advancement and range of surgical excision. Thyroid Res. doi:10.​1186/​1756-6614-3-8 PubMedCentralPubMed
16.
go back to reference Zhao Y, Zhang Y, Liu XJ, Shi BY (2012) Prognostic factors for differentiated thyroid carcinoma and review of the literature. Tumori. 98(2):233–237PubMed Zhao Y, Zhang Y, Liu XJ, Shi BY (2012) Prognostic factors for differentiated thyroid carcinoma and review of the literature. Tumori. 98(2):233–237PubMed
17.
go back to reference Lin JD, Liou MJ, Chao TC, Weng HF, Ho YS (1999) Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases. Endocr Relat Cancer 6(1):109–115PubMedCrossRef Lin JD, Liou MJ, Chao TC, Weng HF, Ho YS (1999) Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases. Endocr Relat Cancer 6(1):109–115PubMedCrossRef
18.
go back to reference Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Uruno T, Akaishi J, Kameyama K, Ito K (2011) Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. Thyroid 21(7):751–757PubMedCrossRef Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Uruno T, Akaishi J, Kameyama K, Ito K (2011) Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. Thyroid 21(7):751–757PubMedCrossRef
19.
go back to reference Nowak W, Szybiński P, Nowak K, Stachura J, Popiela T (2004) Prognostic factors influencing survival after surgical treatment of well differentiated thyroid cancer. Wiad Lek 57(9–10):431–437PubMed Nowak W, Szybiński P, Nowak K, Stachura J, Popiela T (2004) Prognostic factors influencing survival after surgical treatment of well differentiated thyroid cancer. Wiad Lek 57(9–10):431–437PubMed
20.
go back to reference Ibrahimpasic T, Ghossein R, Carlson DL, Nixon I, Palmer FL, Shaha AR, Patel SG, Tuttle RM, Shah JP, Ganly I (2014) Outcomes in patients with poorly differentiated thyroid carcinoma. J Clin Endocrinol Metab 99(4):1245–1252PubMedCrossRef Ibrahimpasic T, Ghossein R, Carlson DL, Nixon I, Palmer FL, Shaha AR, Patel SG, Tuttle RM, Shah JP, Ganly I (2014) Outcomes in patients with poorly differentiated thyroid carcinoma. J Clin Endocrinol Metab 99(4):1245–1252PubMedCrossRef
21.
go back to reference Lo CY, Chan WF, Lam KY, Wan KY (2005) Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann Surg 242(5):708–715PubMedCentralPubMedCrossRef Lo CY, Chan WF, Lam KY, Wan KY (2005) Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann Surg 242(5):708–715PubMedCentralPubMedCrossRef
22.
go back to reference D’Avanzo A, Treseler P, Ituarte PH, Wong M, Streja L, Greenspan FS, Siperstein AE, Duh QY, Clark OH (2004) Follicular thyroid carcinoma: histology and prognosis. Cancer 100(6):1123–1129PubMedCrossRef D’Avanzo A, Treseler P, Ituarte PH, Wong M, Streja L, Greenspan FS, Siperstein AE, Duh QY, Clark OH (2004) Follicular thyroid carcinoma: histology and prognosis. Cancer 100(6):1123–1129PubMedCrossRef
23.
go back to reference American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 19(11):1167–1214 American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 19(11):1167–1214
24.
go back to reference Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295(18):2164–2167PubMedCrossRef Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295(18):2164–2167PubMedCrossRef
Metadata
Title
Factors related to mortality in patients with papillary and follicular thyroid cancer in long-term follow-up
Authors
Thaís Gomes de Melo
Denise Engelbrecht Zantut-Wittmann
Elizabeth Ficher
Lígia Vera Montalli da Assumpção
Publication date
01-12-2014
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 12/2014
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-014-0131-4

Other articles of this Issue 12/2014

Journal of Endocrinological Investigation 12/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.